Form 4: Arteris Director Isabelle F. Geday Sells 15,550 Shares Under 10b5-1 Trading Plan

Director Isabelle F. Geday of Arteris, Inc. sold 15,550 shares of common stock at an average price of $9.0325 per share on December 4, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Isabelle F. Geday, a director at Arteris, Inc., sold 15,550 shares of common stock on December 4, 2024.
• The sale was executed under a pre-arranged 10b5-1 trading plan adopted on June 6, 2024.
• The shares were sold at a weighted average price of $9.0325 per share.
• The sale occurred in multiple transactions with prices ranging from $9.00 to $9.10 per share.
• Following the transaction, Ms. Geday directly owns 121,213 shares of Arteris, Inc.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by a director under a pre-arranged plan, which is neither positive nor negative for the company's outlook.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and sales under 10b5-1 plans are generally viewed as pre-planned and not necessarily indicative of a change in the director's outlook on the company.

Comparison to Industry Standards

• Sales by insiders are a normal part of the stock market, and the use of 10b5-1 plans is a common practice to avoid accusations of trading on non-public information.
• The sale by Isabelle F. Geday is similar to other insider sales in the technology sector, where executives and directors often have significant stock holdings.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's operations or financial health.

Key Dates

Keywords

insider trading, stock sale, 10b5-1 plan, Arteris, Isabelle Geday, director